I’ve read an article today and I’m so stunned.
The medication Epilim (Sodium Valproate) prescribed for a variety of things Epilepsy, Migraine, Depression, Bipolar Disorder etc it would seem the drug company Sanofi want to continue their payroll and profits…….as Epilim is now being prescribed for Obesity.
As always Sanofi have totally contradicted themselves. Epilim is renowned for its increase in Weight Gain and has been published by Sanofi on the PILS leaflet (Patient Information Leaflet) that a side effect of Epilim is Weight Gain. I, myself was on Epilim for a good few years. My appetite definately increased, I was always hungry so with that was the obvious weight gain and I’m not just talking a few lbs ……. a good 4 stone. We have spoke to a number of ladies who have also been on Epilim and they themselves have put weight on.
Here at FACSA we currently understand that Epilim is being prescribed OFF LABEL which means it does not hold a licscense to be prescribed. In Britain MHRA (Medicines and Health Regulatory Association) govern every medicine that is allocated to be prescribed. It would seem in todays world, its not about patient safety, duty of care, making sure patients have the correct information……but its more about keeping drug companies in the money to help and support themselves in their high flying careers and lives.